[EN] COMBINATIONS COMPRISING ALPHA-2-DELTA LIGANDS AND EP4 RECEPTOR ANTAGONISTS<br/>[FR] COMBINAISONS CONTENANT DES LIGANDS DE ALPHA-2-DELTA
申请人:PFIZER PROD INC
公开号:WO2005102389A9
公开(公告)日:2009-04-30
COMBINATIONS COMPRISING ALPHA-2-DELTA LIGANDS AND EP4 RECEPTOR ANTAGONISTS
申请人:Pfizer Products Incorporated
公开号:EP1740211A2
公开(公告)日:2007-01-10
ORTHO SUBSTITUTED ARYL OR HETEROARYL AMIDE COMPOUNDS
申请人:Pfizer, Inc.
公开号:EP1756043A1
公开(公告)日:2007-02-28
[EN] COMBINATIONS COMPRISING ALPHA-2-DELTA LIGANDS<br/>[FR] COMBINAISONS CONTENANT DES LIGANDS DE ALPHA-2-DELTA
申请人:PFIZER PROD INC
公开号:WO2005102389A2
公开(公告)日:2005-11-03
The instant invention relates to a combination of an EP4-receptor antagonist and an alpha-2-delta ligand, and pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof and their use in the treatment of pain, particularly inflammatory, neuropathic, visceral and nociceptive pain.
[EN] ORTHO SUBSTITUTED ARYL OR HETEROARYL AMIDE COMPOUNDS<br/>[FR] COMPOSES ARYL- OU HETEROARYLAMIDES ORTHO-SUBSTITUES
申请人:PFIZER JAPAN INC
公开号:WO2005105733A1
公开(公告)日:2005-11-10
The invention provides a compound of the formula (I): wherein X represents a carbon atom or the like : Y represents imino, or the like: Z represents a hydrogen atom or the like: R1 represents an alkyl group having from 1 to 6 carbon atoms or the like: R2 and R3 independently represents a hydrogen atom or the like. These compounds are useful for the treatment of disease conditions mediated by prostaglandin such as pain, or the like in mammalian. This invention also provides a pharmaceutical composition comprising the above compound.